Endothelium: Interface between coagulation and inflammation

被引:125
作者
Levi, M [1 ]
ten Cate, H
van der Poll, T
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1012 WX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1012 WX Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Expt Med Lab, NL-1012 WX Amsterdam, Netherlands
关键词
antithrombin; coagulation; cytokine; protein C; sepsis; thrombin; tissue factor; tissue factor pathway inhibitor;
D O I
10.1097/00003246-200205001-00008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective., To review the involvement of endothelial cells in the pathogenesis of coagulation abnormalities during severe infection, the differential role of proinflammatory cytokines in these mechanisms, and the cross talk between coagulation and inflammation. Data Sources. Published articles on experimental studies of coagulation activation during Inflammation and clinical studies of patients with sepsis and associated hemostatic abnormalities. Data Synthesis and Conclusion; The endothelium plays a central role in all major pathways involved in the pathogenesis of the hemostatic derangement observed during severe Inflammation (i.e., initiation and regulation of thrombin generation and inhibition of fibrinolysis). Rather than being a unidirectional relationship, the Interaction between inflammation and coagulation Involves significant cross talk in which the endothelium seems to play a pivotal role.
引用
收藏
页码:S220 / S224
页数:5
相关论文
共 52 条
[1]   Vascular bed-specific hemostasis: Role of endothelium in pathogenesis [J].
Aird, WC .
CRITICAL CARE MEDICINE, 2001, 29 (07) :S28-S34
[2]  
ALTIERI DC, 1994, J BIOL CHEM, V269, P3139
[3]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[4]   PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES [J].
BIEMOND, BJ ;
LEVI, M ;
TENCATE, H ;
VANDERPOLL, T ;
BULLER, HR ;
HACK, CE ;
TENCATE, JW .
CLINICAL SCIENCE, 1995, 88 (05) :587-594
[5]   GLYCOSAMINOGLYCANS AND THE REGULATION OF BLOOD-COAGULATION [J].
BOURIN, MC ;
LINDAHL, U .
BIOCHEMICAL JOURNAL, 1993, 289 :313-330
[6]  
Butthep P, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P246
[7]   Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa [J].
Camerer, E ;
Huang, W ;
Coughlin, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5255-5260
[8]   Cell biology of tissue factor, the principal initiator of blood coagulation [J].
Camerer, E ;
Kolsto, AB ;
Prydz, H .
THROMBOSIS RESEARCH, 1996, 81 (01) :1-41
[9]   TISSUE FACTOR PATHWAY INHIBITOR REDUCES MORTALITY FROM ESCHERICHIA-COLI SEPTIC SHOCK [J].
CREASEY, AA ;
CHANG, ACK ;
FEIGEN, L ;
WUN, TC ;
TAYLOR, FB ;
HINSHAW, LB .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2850-2860
[10]   Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages [J].
Cunningham, MA ;
Romas, P ;
Hutchinson, P ;
Holdsworth, SR ;
Tipping, PG .
BLOOD, 1999, 94 (10) :3413-3420